Proteon Pharmaceuticals is delighted to announce that the Ministry of Agriculture, Livestock Farming and Supplies (MAPA) in Brazil has registered BAFASAL PRO, our latest bacteriophage-based
ProteonPharmaceuticals is excited to announce that the European Food Safety Authority (EFSA) has published a positive scientific opinion on our innovative product BAFASAL®. The opinion
At Proteon Pharmaceuticals S.A., we’re dedicated to supporting the growth of future scientists and professionals. This summer, we offered the internships to six students, eager
Proteon Pharmaceuticals is thrilled to announce the obtaining of a new European patent for our pioneering technology: “Method and Kit for Detection of Extraintestinal E.
We are excited to introduce our new video series “Inside Innovation: Micro Talks with the CEO”, launching today on our social media channels. In this
Proteon Pharmaceuticals is glad to announce the latest findings from our recent studies: “A Rapid and Inexpensive PCR Test for Mastitis Diagnosis Based on NGS
Our dedicated Research and Development Team is thrilled to announce the results of one of the recently conducted breakthrough studies: “Novel multiplex-PCR test for Escherichia
In the recent report prepared by the Executive Forecast, Professor Jarosław Dastych shared his passion for bacteriophage technology and threw light upon how it can
Proteon Pharmaceuticals S.A. is pleased to announce the launch of their latest manufacturing facility in India. This 700-metre square factory is designed with cutting-edge zones
Proteon Pharmaceuticals S.A. is delighted to announce the appointment of Márcio Caparroz as our new Chief Commercial Officer (CCO), starting 1st March 2024. Márcio brings